Veradermics is trading 4.96% up at $107.33 as biotechnology and broader markets rally following the Federal Reserve decision and easing risk sentiment.
- No new company-specific announcement was identified on September 17, 2026.
- Recent coverage highlights future VDPHL01 clinical readouts and bullish analyst targets.
- The active biotech sector trend and stronger major indexes provide the clearest explanation for today’s move.